Latvia - Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use
Since 2014, Latvia Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use jumped by 7.2% year on year. In 2019, the country was number 25 among other countries in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use at 47.2 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Latvia is overtaken by Slovakia, which was ranked number 24 with 49.4 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by South Korea with 46.6 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Netherlands ranked the highest with 131.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is a growth of 3.9% versus 2018. Spain, United Kingdom and Iceland respectively ranked number 2, 3 and 4 in this ranking. Canada witnessed the best average annual growth at +11.3% per year, while Austria recorded the worst performance at -14% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 47.20 |
| 2018 | 43.90 |
| 2017 | 42.00 |
| 2016 | 40.10 |
| 2015 | 37.70 |
How does Latvia rank in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Netherlands
|
132 | 2019 | +3.9 % | +3.5 % | View data | |
| 2 |
#2
Spain
|
129 | 2019 | +2.8 % | +0.6 % | View data | |
| 24 |
#24
Slovakia
|
49 | 2019 | +3.6 % | +1.9 % | View data | |
| 25 |
#25
Latvia
|
47 | 2019 | +7.5 % | +7.2 % | View data | |
| 26 |
#26
South Korea
|
47 | 2019 | -0.4 % | +0.6 % | View data | |